Caroline Blakely
Known title: DirectorCIK: 0001600619
Associated companies
Transaction History
| ACRE | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 | View on chart |
| ACRE | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 | View on chart |
| ACRE | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 | View on chart |
| ACRE | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 | View on chart |
| ACRE | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
ACRE Faces Scrutiny Over High Dividend and Valuation
Recent articles highlight concerns about Ares Commercial Real Estate's 13.27% dividend yield, with one piece suggesting it is less sustainable than peers. Another notes the stock trades at a significant discount to book value. These discussions occur while the stock remains near its 52-week low, reflecting ongoing investor debate about the company's payout structure versus its valuation.
ACRE Faces Scrutiny Over High Dividend and Valuation. Recent articles highlight concerns about Ares Commercial Real Estate's 13.27% dividend yield, with one piece suggesting it is less sustainable than peers. Another notes the stock trades at a significant discount to book value. These discussions occur while the stock remains near its 52-week low, reflecting ongoing investor debate about the company's payout structure versus its valuation.